He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
The company has posted net profit) of Rs.18.88 crores for the Financial Year ended March 31, 2024
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Carbogen Amcis Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The company has reported total income of Rs. 77.60 crores during the period ended September 30, 2022
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
The consideration for the acquisition is US $ 2.25 million
Subscribe To Our Newsletter & Stay Updated
